Large Scale Production of Mouse Interferons from Monolayers of Ehrlich Ascites Tumour Cells

References

1. Berthold W., Tan C., Tan Y. H. 1978; Purification and in vitro labeling of interferon from a human fibroblastoid cell line. Journal of Biological Chemistry 253:5206–5212
   [Google Scholar]
2. Cabrer B., Taira H., Broeze R. J., Kempe T. D., Williams K., Slattery E., Konigsberg W. H., Lengyel P. 1979; Structural characteristics of interferons from mouse Ehrlich ascites tumor cells. Journal of Biological Chemistry 254:3681–3684
   [Google Scholar]
3. Cantell K., Paucker K. 1963; Quantitative studies on viral interference in suspended L cells. IV. Production and assay of interferon. Virology 21:11–21
   [Google Scholar]
4. Demaeyer-Guignard J., Tovey M. G., Gresser I., Demaeyer E. 1978; Purification of mouse interferon by sequential affinity chromatography on poly(U)- and antibody-agarose columns. Nature, London 271:622–625
   [Google Scholar]
5. Fujisawa J., Iwakura Y., Kawade Y. 1978; Nonglycosylated mouse L cell interferon produced by the action of tunicamycin. Journal of Biological Chemistry 253:8677–8679
   [Google Scholar]
6. Henderson D. R., Joklik W. K. 1978; The mechanism of interferon induction by UV-irradiated reovirus. Virology 91:389–406
   [Google Scholar]
7. Henle W., Henle G., Deinhardt F., Bergs V. V. 1959; Studies on persistent infections in tissue cultures. IV. Evidence for the production of an interferon in MCN cells by myxoviruses. Journal of Experimental Medicine no:525–541
   [Google Scholar]
8. Isaacs A., Burke D. C. 1958; Mode of action of interferons. Nature, London 182:1073–1074
   [Google Scholar]
9. Isaacs A., Lindenmann J. 1957; Virus interference. I. The interferon. Proceedings of the Royal Society B 147:258–267
   [Google Scholar]
10. Iwakura Y., Yonehara S., Kawade Y. 1978a; Purification of mouse L cell interferon. Essentially pure preparations with associated cell growth inhibitory activity. Journal of Biological Chemistry 253:5074–5079
    [Google Scholar]
11. Iwakura Y., Yonehara S., Kawade Y. 1978b; Presence of a common structure in the two molecular species of mouse L cell interferon. Biochemical and Biophysical Research Communications 84:557–563
    [Google Scholar]
12. Kawakita M., Cabrer B., Taira H., Rebello M., Slattery E., Weideli H., Lengyel P. 1978; Purification of interferon from mouse Ehrlich ascites tumor cells. Journal of Biological Chemistry 253:598–602
    [Google Scholar]
13. Knight E. Jun 1975; Heterogeneity of purified mouse interferons. Journal of Biological Chemistry 250:4139–4144
    [Google Scholar]
14. Knight E. Jun 1976; Interferon: purification and initial characterization from human diploid cells. Proceedings of the National Academy of Sciences of the United States of America 73:520–523
    [Google Scholar]
15. Oie H. K., Gazdar A. F., Buckler C. E., Baron S. 1972; High interferon producing line of transformed murine cells. Journal of General Virology 17:107–109
    [Google Scholar]
16. Rubinstein M., Rubinstein S., Familletti P. C., Miller R. S., Waldman A. A., Pestka S. 1979; Human leukocyte interferon: production, purification to homogeneity, and initial characterization. Proceedings of the National Academy of Sciences of the United States of America 76:640–644
    [Google Scholar]
17. Sehgal P. B., Tamm I., Vilcek J. 1975; Human interferon production: superinduction by 5, 6-dichloro-I-β-D-ribofuranosylbenzimidazole. Science 190:282–284
    [Google Scholar]
18. Slattery E., Taira H., Broeze R., Lengyel P. 1980; Mouse interferons: production by Ehrlich ascites tumour cells infected with Newcastle disease virus and its enhancement by theophylline. Journal of General Virology 49: (in the press)
    [Google Scholar]
19. Stewart W. E., Gosser L. B. II, Lockart R. Z. Jun 1971; Priming: a nonantiviral function of interferon. Journal of Virology 7:792–801
    [Google Scholar]
20. Taira H., Broeze R. J., Jayaram B. M., Lengyel P., Hunkapiller M., Hood L. E. 1980; Mouse interferons: NH₂-terminal amino acid sequences of various species. Science 207:528–530
    [Google Scholar]
21. Tan Y. H., Armstrong J. A., Ke Y. M., Ho M. 1970; Regulation of cellular interferon production: enhancement by antimetabolites. Proceedings of the National Academy of Sciences of the United States of America 67:464–471
    [Google Scholar]
22. Tan Y. H., Armstrong J. A., Ho M. 1971; Accentuation of interferon production by metabolic inhibitors and its dependence on protein synthesis. Virology 44:503–509
    [Google Scholar]
23. Tovey M. G., Begon-Lours J., Gresser I. 1974; A method for the large scale production of potent interferon preparations. Proceedings of the Society for Experimental Biology and Medicine 146:809–815
    [Google Scholar]
24. Vilcek J., Rossman T. G., Varacalli F. 1969; Differential effects of actinomycin D and puromycin on the release of interferon induced by double-stranded RNA. Nature, London 222:682–684
    [Google Scholar]
25. Wiranowska-Stewart M., Chudizo T., Stewart W. E. II 1977; Repeated ‘superinduction’ of interferon in human diploid fibroblast culture. Journal of General Virology 37:221–223
    [Google Scholar]